市場調査レポート
商品コード
1494339

アジア太平洋の経腸栄養市場の2030年予測-地域別分析-製品タイプ、用途、年齢層、流通チャネル別

Asia Pacific Enteral Nutrition Market Forecast to 2030 - Regional Analysis - by Product Type, Application, Age Group, and Distribution Channel

出版日: | 発行: The Insight Partners | ページ情報: 英文 121 Pages | 納期: 即納可能 即納可能とは

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=158.49円
アジア太平洋の経腸栄養市場の2030年予測-地域別分析-製品タイプ、用途、年齢層、流通チャネル別
出版日: 2024年03月14日
発行: The Insight Partners
ページ情報: 英文 121 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 図表
  • 目次
概要

アジア太平洋の経腸栄養市場は、2022年に17億9,110万米ドルと評価され、2030年には29億4,272万米ドルに達すると予測され、2022年から2030年までのCAGRは6.4%で成長すると予測されています。

主要市場企業の戦略的取り組みがアジア太平洋の経腸栄養市場を後押し

経腸栄養市場で事業を展開する企業は、提携、拡大、合意、パートナーシップ、新製品発売などの戦略的開拓に継続的に注力しています。これらは、売上の向上、地理的範囲の拡大、既存顧客よりも多くの顧客層に対応するための能力強化に役立っています。経腸栄養市場における注目すべき開拓のいくつかを以下に挙げる:

  • 2022年6月、ネスレヘルスサイエンスはCDHインベストメンツとTBHCの創業株主からザ・ベター・ヘルス・カンパニー(TBHC)を買収しました。この買収には、GO Healthyブランド、ビタミンとサプリメントのラインナップ、マヌカハニーブランドのEgmont、オークランドにあるビタミン、ミネラル、サプリメントの製造施設New Zealand Health Manufacturingが含まれます。この買収により、ネスレヘルスサイエンスはニュージーランド、オーストラリア、その他のアジア太平洋諸国におけるプレゼンスを強化・拡大しました。
  • 2021年9月、アボット社は、経管栄養に頼る人々のために、植物性タンパク質と有機食品素材-ペディアシュア・ハーベストとエンシュア・ハーベストを発表しました。ハーベスト製品は、単独で栄養補給することも、1日の栄養所要量を満たす補助食品として使用することもできます。
  • 2020年10月、ニュートリシア(ダノン傘下)はReal Food Blends社を買収しました。同社はリアルフードブレンドのミッションに沿って、経管栄養に依存する小児および成人にユニークで栄養価の高い選択肢を提供します。
  • したがって、経腸栄養市場の企業は、すぐに飲める栄養補助食品やすぐに使える栄養補助食品などの製品の導入、さまざまな健康問題をターゲットにした革新的な製品の開拓、事業拡大や買収などの戦略的な動きによって、新製品や改良品、新規事業を生み出し、市場での競争力を維持することができます。したがって、このような戦略的成長イニシアティブは市場に大きな成長機会を生み出します。

アジア太平洋の経腸栄養市場の概要

アジア太平洋の経腸栄養市場は、中国、日本、インド、韓国、オーストラリア、その他アジア太平洋に区分されます。同地域の市場成長に寄与する要因には、慢性疾患の有病率の上昇や、同地域全体で市場企業の存在感が高まっていること、経腸栄養製品の製造量が最も多いことなどがあります。さらに、政府の積極的な取り組みや栄養分野における研究が市場の成長を後押ししています。オーストラリア、インド、韓国などの国々は、医療セクターの発展が著しいため、さまざまな成長機会を目撃することになると推定されます。さらに、これらの国の政府は経腸・非経口栄養の提供に向けた取り組みを強化しています。

神経疾患の有病率の上昇と経腸栄養の採用拡大が市場の成長を後押ししています。中国では高齢者人口が大幅に増加しています。脳卒中は全国の高齢者の主な死因となっています。Elsevier誌に掲載された研究によると、2020年には脳卒中の症例が1,780万件、新たな脳卒中が340万件、脳卒中関連死が230万件報告されています。この数字に影響を及ぼしている要因としては、脳卒中予防教育に対する政府の支援、脳卒中に関する一般市民の知識の向上、治療選択肢や医療技術の改善、ヘルスケア適用範囲や医療環境の改善などが挙げられます。脳卒中は急性嚥下障害の最も一般的な原因であり、栄養不良を引き起こし、QOLに影響を与える可能性があります。中国では、重症の脳卒中患者に対する経管栄養が経腸栄養改善戦略として実施されています。

アジア太平洋の経腸栄養市場の収益と2030年までの予測(金額)

アジア太平洋の経腸栄養市場のセグメンテーション

アジア太平洋の経腸栄養市場は、製品タイプ、用途、年齢層、流通チャネル、国によって区分されます。

製品タイプに基づいて、アジア太平洋の経腸栄養市場は一般的なものと疾患特異的なものに二分されます。2022年のアジア太平洋の経腸栄養市場は、一般セグメントが大きなシェアを占めています。

用途別では、アジア太平洋の経腸栄養市場は、胃腸障害、代謝/先天性代謝異常、食物アレルギー、腎臓病、肝臓病、腫瘍学、神経学、その他に区分されます。胃腸障害セグメントは、2022年にアジア太平洋の経腸栄養剤市場で最大のシェアを占めました。

年齢層に基づいて、アジア太平洋の経腸栄養市場は成人と小児に二分されます。成人セグメントは、2022年にアジア太平洋の経腸栄養市場においてより大きなシェアを占めました。

流通チャネル別では、アジア太平洋の経腸栄養市場は病院薬局、小売店、eコマース、その他に区分されます。病院薬局セグメントは、2022年にアジア太平洋の経腸栄養剤市場で最大のシェアを占めました。

国別では、アジア太平洋の経腸栄養市場は中国、日本、インド、オーストラリア、韓国、その他アジア太平洋に分類されます。2022年のアジア太平洋の経腸栄養市場は中国が支配的でした。

Abbott Laboratories社、Nestle SA社、Danone SA社、Fresenius SE &Co KGaA社、B Braun SE社、Reckitt Benckiser Group Plc社、Royal FrieslandCampina NV社、Arla Foods amba社、Perrigo Co Plc社、Fonterra Co-Operative Group Ltd社は、アジア太平洋の経腸栄養剤市場で事業を展開している大手企業の一部です。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

  • 主要な洞察

第3章 調査手法

  • 調査範囲
  • 2次調査
  • 1次調査

第4章 アジア太平洋の経腸栄養市場:主要産業力学

  • 主な市場促進要因
    • 胃腸疾患の有病率の増加
    • 栄養不良および早産事例の増加
  • 市場抑制要因
    • 経腸栄養システムに関連する合併症
  • 市場機会
    • 主要市場企業の戦略的取り組み
  • 今後の動向
    • 特定の処方と植物ベースの栄養製品
  • 影響分析

第5章 経腸栄養市場-アジア太平洋市場分析

  • アジア太平洋の経腸栄養市場の売上高、2022年~2030年

第6章 アジア太平洋の経腸栄養市場-2030年までの収益と予測-製品タイプ別

  • アジア太平洋の経腸栄養剤市場:2022年および2030年の製品タイプ別売上高シェア(%)
  • 一般
  • 疾患特異的

第7章 アジア太平洋の経腸栄養市場:用途別収益と2030年までの予測

  • アジア太平洋の経腸栄養剤市場:2022年および2030年の用途別売上高シェア(%)
  • 胃腸障害
  • 代謝/先天性代謝異常
  • アレルギー
  • 腎疾患
  • 肝臓疾患
  • 腫瘍学
  • 神経学
  • その他

第8章 アジア太平洋の経腸栄養市場:2030年までの収益と予測:年齢層別

  • アジア太平洋の経腸栄養剤市場:2022年および2030年の年齢層別売上高シェア(%)
  • 成人
  • 小児

第9章 アジア太平洋の経腸栄養市場-2030年に至る収益と予測-流通経路別

  • アジア太平洋の経腸栄養剤市場:2022年・2030年流通チャネル別売上高シェア(%)
  • 病院薬局
  • 小売店
  • eコマース
  • その他

第10章 アジア太平洋の経腸栄養市場:国別分析

  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他アジア太平洋

第11章 経腸栄養市場-業界情勢

  • 経腸栄養市場における成長戦略
  • 無機的成長戦略
  • 有機的成長戦略

第12章 企業プロファイル

  • Abbott Laboratories
  • Nestle SA
  • Danone SA
  • Fresenius SE & Co KGaA
  • B Braun SE
  • Reckitt Benckiser Group Plc
  • Royal FrieslandCampina NV
  • Arla Foods amba
  • Perrigo Co Plc
  • Fonterra Co-Operative Group Ltd

第13章 付録

図表

List Of Tables

  • Table 1. Asia Pacific Enteral Nutrition Market Segmentation
  • Table 2. Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - General
  • Table 3. Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 4. China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 5. China Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 6. China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 7. China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 8. China Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 9. China Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 10. Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 11. Japan Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 12. Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 13. Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 14. Japan Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 15. Japan Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 16. India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 17. India Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 18. India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 19. India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 20. India Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 21. India Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 22. Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 23. Australia Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 24. Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 25. Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 26. Australia Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 27. Australia Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 28. South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 29. South Korea Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 30. South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 31. South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 32. South Korea Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 33. South Korea Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 34. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Product Type
  • Table 35. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - General
  • Table 36. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Elemental Formula
  • Table 37. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million) - Application
  • Table 38. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Age Group
  • Table 39. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast To 2030 (US$ million) - Distribution Channel
  • Table 40. Recent Inorganic Growth Strategies in the Enteral Nutrition Market
  • Table 41. Recent Organic Growth Strategies in the Enteral Nutrition Market
  • Table 42. Glossary of Terms, Enteral Nutrition Market

List Of Figures

  • Figure 1. Asia Pacific Enteral Nutrition Market Segmentation, By Country
  • Figure 2. Asia Pacific Enteral Nutrition Market - Key Industry Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Enteral Nutrition Market Revenue (US$ million), 2020 - 2030
  • Figure 5. Asia Pacific Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • Figure 6. General: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Disease Specific: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Asia Pacific Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 9. Gastrointestinal Disorder: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Metabolic/Inborn Errors of Metabolism: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Allergy: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Renal Disease: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Liver Disease: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oncology: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Neurology: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Others: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Asia Pacific Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • Figure 18. Adult: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Pediatric: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Asia Pacific Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 21. Hospital Pharmacies: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Retail Stores: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. E-Commerce: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Enteral Nutrition Market, By Country, 2022 (US$ Million)
  • Figure 26. Asia Pacific Enteral Nutrition Market, By Key Countries, 2022 and 2030 (%)
  • Figure 27. China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 28. Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 29. India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 30. Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 31. South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 32. Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
  • Figure 33. Growth Strategies in the Enteral Nutrition Market
目次
Product Code: BMIRE00029864

The Asia Pacific enteral nutrition market was valued at US$ 1,791.10 million in 2022 and is expected to reach US$ 2,942.72 million by 2030; it is estimated to grow at a CAGR of 6.4% from 2022 to 2030.

Strategic Initiatives by Key Market Players Fuel Asia Pacific Enteral Nutrition Market

Companies operating in the enteral nutrition market continuously focus on strategic developments such as collaborations, expansions, agreements, partnerships, and new product launches. These help them improve their sales, expand their geographic reach, and enhance their capacities to cater to a larger than existing customer base. A few of the noteworthy developments in the enteral nutrition market are mentioned below:

  • In June 2022, Nestle Health Science acquired The Better Health Company (TBHC) from CDH Investments and TBHC's founding shareholders. The acquisition includes the GO Healthy brand; vitamin and supplement lineups; Egmont, the Manuka honey brand; and New Zealand Health Manufacturing, an Auckland-based manufacturing facility for vitamins, minerals, and supplements. The acquisition helped Nestle Health Science strengthen and expand its presence in New Zealand, Australia, and other Asia Pacific countries.
  • In September 2021, Abbott introduced plant-based protein and organic food ingredients-PediaSure Harvest and Ensure Harvest-for people relying on feeding tubes. Harvest products can be used as sole-source nutrition or a supplement to satisfy daily nutrition requirements.
  • In October 2020, Nutricia (part of Danone) acquired Real Food Blends. The company brings unique and nutritious choices to children and adults dependent on feeding tubes, in line with its real food blends mission.
  • Therefore, introducing products such as ready-to-drink and ready-to-use nutritional supplements, the development of innovative products targeting various health issues, and strategic moves such as expansions and acquisitions allow companies in the enteral nutrition market to create new or improved products and new business to remain competitive in the market. Thus, such strategic growth initiatives create significant growth opportunities in the market.

Asia Pacific Enteral Nutrition Market Overview

The Asia Pacific enteral nutrition market is segmented into China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific. The factors contributing to the market progress in this region include the rising prevalence of chronic diseases and the growing presence of market players across the region, conferring the highest manufacturing of enteral nutrition products. Furthermore, supportive government initiatives and research in the field of nutrition boost market growth. Countries such as Australia, India, and South Korea are estimated to witness various growth opportunities due to the rising development in the healthcare sector. In addition, governments of these countries are increasing their efforts to provide enteral and parenteral nutrition.

The rising prevalence of neurological diseases and the growing adoption of enteral nutrition are boosting the market's growth. China has experienced a significant rise in the elderly population. Stroke is the leading cause of death among older people across the country. According to the study published in Elsevier, in 2020, 17.8 million cases of stroke, 3.4 million new strokes, and 2.3 million stroke-related deaths were reported. The factors that have affected the numbers are the support of the government to educate the public on stroke prevention, better public knowledge of stroke, improved treatment options and medical technology, and improved healthcare coverage and healthcare environment, among others. Stroke is the most common cause of acute dysphagia, which may lead to malnutrition and impact the quality of life. Tube feeding of critically ill stroke patients was implemented as an enteral nutrition improvement strategy in China.

Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ Million)

Asia Pacific Enteral Nutrition Market Segmentation

The Asia Pacific enteral nutrition market is segmented based on product type, application, age group, distribution channel, and country.

Based on product type, the Asia Pacific enteral nutrition market is bifurcated into general and disease specific. The general segment held a larger Asia Pacific enteral nutrition market share in 2022.

In terms of application, the Asia Pacific enteral nutrition market is segmented into gastrointestinal disorders, metabolic/inborn errors of metabolism, food allergy, renal disease, liver disease, oncology, neurology, and others. The gastrointestinal disorders segment held the largest Asia Pacific enteral nutrition market share in 2022.

Based on age group, the Asia Pacific enteral nutrition market is bifurcated into adult and pediatric. The adult segment held a larger Asia Pacific enteral nutrition market share in 2022.

By distribution channel, the Asia Pacific enteral nutrition market is segmented into hospital pharmacies, retail stores, e-commerce, and others. The hospital pharmacies segment held the largest Asia Pacific enteral nutrition market share in 2022.

Based on country, the Asia Pacific enteral nutrition market is categorized into China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific. China dominated the Asia Pacific enteral nutrition market in 2022.

Abbott Laboratories, Nestle SA, Danone SA, Fresenius SE & Co KGaA, B Braun SE, Reckitt Benckiser Group Plc, Royal FrieslandCampina NV, Arla Foods amba, Perrigo Co Plc, and Fonterra Co-Operative Group Ltd are some of the leading companies operating in the Asia Pacific enteral nutrition market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Asia Pacific Enteral Nutrition Market - Key Industry Dynamics

  • 4.1 Key Market Drivers:
    • 4.1.1 Increasing Prevalence of Gastrointestinal Diseases
    • 4.1.2 Rising Cases of Malnutrition and Premature Births
  • 4.2 Market Restraints
    • 4.2.1 Complications Associated with Enteral Feeding Systems
  • 4.3 Market Opportunities
    • 4.3.1 Strategic Initiatives by Key Market Players
  • 4.4 Future Trends
    • 4.4.1 Specific Formulations and Plant-Based Nutrition Products
  • 4.5 Impact Analysis

5. Enteral Nutrition Market - Asia Pacific Market Analysis

  • 5.1 Asia Pacific Enteral Nutrition Market Revenue (US$ million), 2022 - 2030

6. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Product Type

  • 6.1 Overview
  • 6.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Product Type 2022 & 2030 (%)
  • 6.3 General
    • 6.3.1 Overview
    • 6.3.2 General: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Asia Pacific Enteral Nutrition Market, by General
        • 6.3.2.1.1 Asia Pacific Enteral Nutrition Market, by Elemental Formula
  • 6.4 Disease Specific
    • 6.4.1 Overview
    • 6.4.2 Disease Specific: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

7. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Gastrointestinal Disorder
    • 7.3.1 Overview
    • 7.3.2 Gastrointestinal Disorder: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Metabolic/Inborn Errors of Metabolism
    • 7.4.1 Overview
    • 7.4.2 Metabolic/Inborn Errors of Metabolism: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Allergy
    • 7.5.1 Overview
    • 7.5.2 Allergy: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Renal Disease
    • 7.6.1 Overview
    • 7.6.2 Renal Disease: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Liver Disease
    • 7.7.1 Overview
    • 7.7.2 Liver Disease: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.8 Oncology
    • 7.8.1 Overview
    • 7.8.2 Oncology: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.9 Neurology
    • 7.9.1 Overview
    • 7.9.2 Neurology: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.10 Others
    • 7.10.1 Overview
    • 7.10.2 Others: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

8. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Age Group

  • 8.1 Overview
  • 8.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Age Group 2022 & 2030 (%)
  • 8.3 Adult
    • 8.3.1 Overview
    • 8.3.2 Adult: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Pediatric
    • 8.4.1 Overview
    • 8.4.2 Pediatric: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

9. Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 9.1 Overview
  • 9.2 Asia Pacific Enteral Nutrition Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 9.3 Hospital Pharmacies
    • 9.3.1 Overview
    • 9.3.2 Hospital Pharmacies: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Retail Stores
    • 9.4.1 Overview
    • 9.4.2 Retail Stores: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 E-Commerce
    • 9.5.1 Overview
    • 9.5.2 E-Commerce: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.6 Others
    • 9.6.1 Overview
    • 9.6.2 Others: Asia Pacific Enteral Nutrition Market - Revenue and Forecast to 2030 (US$ Million)

10. Asia Pacific Enteral Nutrition Market - Country Analysis

  • 10.1 Asia Pacific Enteral Nutrition Market, Revenue and Forecast to 2030
    • 10.1.1 Asia Pacific Enteral Nutrition Market by Country
      • 10.1.1.1 China
        • 10.1.1.1.1 Overview
        • 10.1.1.1.2 China Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.1.3 China Enteral Nutrition Market, by Product Type
        • 10.1.1.1.3.1 China Enteral Nutrition Market, by General
        • 10.1.1.1.3.1.1 China Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.1.4 China Enteral Nutrition Market, by Application
        • 10.1.1.1.5 China Enteral Nutrition Market, by Age Group
        • 10.1.1.1.6 China Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.2 Japan
        • 10.1.1.2.1 Overview
        • 10.1.1.2.2 Japan Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.2.3 Japan Enteral Nutrition Market, by Product Type
        • 10.1.1.2.3.1 Japan Enteral Nutrition Market, by General
        • 10.1.1.2.3.1.1 Japan Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.2.4 Japan Enteral Nutrition Market, by Application
        • 10.1.1.2.5 Japan Enteral Nutrition Market, by Age Group
        • 10.1.1.2.6 Japan Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.3 India
        • 10.1.1.3.1 Overview
        • 10.1.1.3.2 India Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.3.3 India Enteral Nutrition Market, by Product Type
        • 10.1.1.3.3.1 India Enteral Nutrition Market, by General
        • 10.1.1.3.3.1.1 India Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.3.4 India Enteral Nutrition Market, by Application
        • 10.1.1.3.5 India Enteral Nutrition Market, by Age Group
        • 10.1.1.3.6 India Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.4 Australia
        • 10.1.1.4.1 Overview
        • 10.1.1.4.2 Australia Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.4.3 Australia Enteral Nutrition Market, by Product Type
        • 10.1.1.4.3.1 Australia Enteral Nutrition Market, by General
        • 10.1.1.4.3.1.1 Australia Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.4.4 Australia Enteral Nutrition Market, by Application
        • 10.1.1.4.5 Australia Enteral Nutrition Market, by Age Group
        • 10.1.1.4.6 Australia Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.5 South Korea
        • 10.1.1.5.1 Overview
        • 10.1.1.5.2 South Korea Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.5.3 South Korea Enteral Nutrition Market, by Product Type
        • 10.1.1.5.3.1 South Korea Enteral Nutrition Market, by General
        • 10.1.1.5.3.1.1 South Korea Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.5.4 South Korea Enteral Nutrition Market, by Application
        • 10.1.1.5.5 South Korea Enteral Nutrition Market, by Age Group
        • 10.1.1.5.6 South Korea Enteral Nutrition Market, by Distribution Channel
      • 10.1.1.6 Rest of Asia Pacific
        • 10.1.1.6.1 Overview
        • 10.1.1.6.2 Rest of Asia Pacific Enteral Nutrition Market Revenue and Forecast to 2030 (US$ million)
        • 10.1.1.6.3 Rest of Asia Pacific Enteral Nutrition Market, by Product Type
        • 10.1.1.6.3.1 Rest of Asia Pacific Enteral Nutrition Market, by General
        • 10.1.1.6.3.1.1 Rest of Asia Pacific Enteral Nutrition Market, by Elemental Formula
        • 10.1.1.6.4 Rest of Asia Pacific Enteral Nutrition Market, by Application
        • 10.1.1.6.5 Rest of Asia Pacific Enteral Nutrition Market, by Age Group
        • 10.1.1.6.6 Rest of Asia Pacific Enteral Nutrition Market, by Distribution Channel

11. Enteral Nutrition Market-Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in the Enteral Nutrition Market
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Nestle SA
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Danone SA
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Fresenius SE & Co KGaA
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 B Braun SE
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Reckitt Benckiser Group Plc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Royal FrieslandCampina NV
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Arla Foods amba
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Perrigo Co Plc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Fonterra Co-Operative Group Ltd
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms